164 related articles for article (PubMed ID: 14769602)
1. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma.
Hayden BC; Murray TG; Cicciarelli N; Scott IU; Alexandridou A; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2002 Mar; 120(3):353-9. PubMed ID: 11879140
[TBL] [Abstract][Full Text] [Related]
3. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
4. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.
Murray TG; Roth DB; O'Brien JM; Feuer W; Cicciarelli N; Markoe AM; Hernández E; Smith BJ; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1385-9. PubMed ID: 8906029
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
[TBL] [Abstract][Full Text] [Related]
6. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
Chan MP; Hungerford JL; Kingston JE; Plowman PN
Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
[TBL] [Abstract][Full Text] [Related]
9. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
10. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
[TBL] [Abstract][Full Text] [Related]
11. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
[TBL] [Abstract][Full Text] [Related]
12. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
[TBL] [Abstract][Full Text] [Related]
13. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
Sussman DA; Escalona-Benz E; Benz MS; Hayden BC; Feuer W; Cicciarelli N; Toledano S; Markoe A; Murray TG
Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
[TBL] [Abstract][Full Text] [Related]
14. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy.
Yousef YA; Mohammad M; Jaradat I; Shatnawi R; Banat S; Mehyar M; Al-Nawaiseh I
Ophthalmic Genet; 2020 Feb; 41(1):20-25. PubMed ID: 32072842
[No Abstract] [Full Text] [Related]
15. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma.
Murray TG; O'Brien JM; Steeves RA; Smith BJ; Albert DM; Cicciarelli N; Markoe AM; Tompkins DT; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1376-81. PubMed ID: 8906028
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
19. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
20. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]